--- title: "High Growth Tech Stocks To Watch In May 2026" type: "News" locale: "en" url: "https://longbridge.com/en/news/285185513.md" description: "As global markets face geopolitical tensions and changing monetary policies, U.S. stocks remain resilient. High-growth tech stocks are highlighted, particularly in sectors like AI. Notable companies include Pharming Group, CELSYS, and Plus Alpha Consulting, each showing strong revenue and earnings growth. Pharming Group reported a revenue increase to $376.13 million and a net profit of $2.85 million, while CELSYS and Plus Alpha Consulting also demonstrated significant growth in their respective markets. These companies are positioned well for future growth amid current market dynamics." datetime: "2026-05-05T10:13:19.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285185513.md) - [en](https://longbridge.com/en/news/285185513.md) - [zh-HK](https://longbridge.com/zh-HK/news/285185513.md) --- # High Growth Tech Stocks To Watch In May 2026 As global markets navigate the complexities of geopolitical tensions and shifting monetary policies, U.S. stocks have shown resilience with major indexes posting gains despite a hawkish Federal Reserve stance and fluctuating oil prices. In this context, identifying high-growth tech stocks involves looking for companies that demonstrate robust earnings potential and innovation in sectors like artificial intelligence, which are poised to benefit from current market dynamics. ### Top 10 High Growth Tech Companies Globally Name Revenue Growth Earnings Growth Growth Rating Hacksaw 25.39% 24.90% ★★★★★★ Shengyi Electronics 26.78% 32.30% ★★★★★★ Delton Technology (Guangzhou) 29.71% 33.06% ★★★★★★ Zhongji Innolight 41.90% 44.62% ★★★★★★ Suzhou TFC Optical Communication 44.06% 41.48% ★★★★★★ Fositek 29.55% 39.17% ★★★★★★ Unimicron Technology 29.87% 54.56% ★★★★★★ KebNi 26.87% 82.69% ★★★★★★ Co-Tech Development 34.37% 65.79% ★★★★★★ CARsgen Therapeutics Holdings 64.21% 83.56% ★★★★★★ Click here to see the full list of 197 stocks from our Global High Growth Tech and AI Stocks screener. Here we highlight a subset of our preferred stocks from the screener. ## Pharming Group (ENXTAM:PHARM) **Simply Wall St Growth Rating:** ★★★★★☆ **Overview:** Pharming Group N.V. is a biopharmaceutical company that focuses on developing and commercializing protein replacement therapies and precision medicines for rare diseases across the United States, Europe, and internationally, with a market cap of €1.01 billion. **Operations:** Pharming Group generates revenue primarily from its products Joenja® and Ruconest®, contributing $58.21 million and $317.92 million, respectively. The company is involved in the biopharmaceutical sector, focusing on rare diseases with a market cap of approximately €1 billion. Pharming Group's recent advancements and financial growth reflect its potential in the biotech sector, particularly with its pioneering treatment, Joenja, for APDS. The company reported a significant turnaround with annual revenue rising to $376.13 million, up from $297.2 million the previous year, and transitioning from a net loss of $11.84 million to a net profit of $2.85 million. This resurgence is bolstered by strategic conference presentations and positive clinical trial outcomes that enhance its market presence in Europe and Japan. With an expected earnings growth of 36.7% per year and R&D focused on addressing rare diseases through innovative treatments, Pharming is positioning itself as a key player in specialized healthcare solutions. - Unlock comprehensive insights into our analysis of Pharming Group stock in this health report. - Understand Pharming Group's track record by examining our Past report. ENXTAM:PHARM Revenue and Expenses Breakdown as at May 2026 ## CELSYS (TSE:3663) **Simply Wall St Growth Rating:** ★★★★☆☆ **Overview:** CELSYS, Inc. operates in Japan providing content creation solutions and has a market cap of approximately ¥39.85 billion. **Operations:** The company focuses on providing content creation solutions in Japan. It generates revenue primarily through software sales and related services, with a notable emphasis on digital illustration and animation tools. CELYS has demonstrated resilience and strategic foresight in its financial operations, particularly evident in its recent corporate actions to optimize treasury shares. With a projected annual earnings growth of 22.3% and revenue increases at 9.7% per year, the company is outpacing the Japanese market average significantly. These figures are bolstered by robust R&D investments that not only underscore CELSYS's commitment to innovation but also align with broader industry trends towards enhanced digital solutions. Recent dividend adjustments reflect a tactical approach to shareholder returns, balancing between reinvestment in growth and direct shareholder value enhancement through dividends expected to rise from JPY 14.00 to JPY 20.00 per share annually. - Delve into the full analysis health report here for a deeper understanding of CELSYS. - Review our historical performance report to gain insights into CELSYS''s past performance. TSE:3663 Earnings and Revenue Growth as at May 2026 ## Plus Alpha ConsultingLtd (TSE:4071) **Simply Wall St Growth Rating:** ★★★★☆☆ **Overview:** Plus Alpha Consulting Co., Ltd. offers marketing and HR solutions within Japan, with a market capitalization of ¥92.33 billion. **Operations:** Plus Alpha Consulting Co., Ltd. generates revenue primarily through its HR solutions, which account for ¥13.84 billion, and marketing solutions, contributing ¥3.79 billion. The company operates exclusively within Japan's market, focusing on these two key segments to drive its business operations. Plus Alpha ConsultingLtd. has recently shown robust financial performance, with a notable increase in quarterly sales from JPY 3.89 billion to JPY 4.44 billion and a surge in net income from JPY 755.55 million to JPY 1.15 billion year-over-year. This growth trajectory is supported by an annual revenue growth rate of 12.5%, outpacing the Japanese market's average of 6%. The company's commitment to innovation is evident from its R&D spending trends, aligning with industry shifts towards more sophisticated digital solutions and ensuring competitiveness in the evolving tech landscape. - Click to explore a detailed breakdown of our findings in Plus Alpha ConsultingLtd's health report. - Learn about Plus Alpha ConsultingLtd's historical performance. TSE:4071 Revenue and Expenses Breakdown as at May 2026 ## Seize The Opportunity - Click this link to deep-dive into the 197 companies within our Global High Growth Tech and AI Stocks screener. - Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. - Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. ## Ready For A Different Approach? - Explore high-performing small cap companies that haven't yet garnered significant analyst attention. - Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. - Find companies with promising cash flow potential yet trading below their fair value. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### **New:** Manage All Your Stock Portfolios in One Place We've created the **ultimate portfolio companion** for stock investors, **and it's free.** • Connect an unlimited number of Portfolios and see your total in one currency • Be alerted to new Warning Signs or Risks via email or mobile • Track the Fair Value of your stocks Try a Demo Portfolio for Free ### Related Stocks - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [IXN.US](https://longbridge.com/en/quote/IXN.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [688183.CN](https://longbridge.com/en/quote/688183.CN.md) - [001389.CN](https://longbridge.com/en/quote/001389.CN.md) - [300308.CN](https://longbridge.com/en/quote/300308.CN.md) - [300394.CN](https://longbridge.com/en/quote/300394.CN.md) - [02171.HK](https://longbridge.com/en/quote/02171.HK.md) - [PHAR.US](https://longbridge.com/en/quote/PHAR.US.md) - [3663.JP](https://longbridge.com/en/quote/3663.JP.md) - [4071.JP](https://longbridge.com/en/quote/4071.JP.md) ## Related News & Research - [LEAP Consulting Group Expands Enterprise AI Practice, Launching Proprietary Maturity Assessment and Agentic Automation Capabilities](https://longbridge.com/en/news/286107443.md) - [The AI legal services industry is heating up. Anthropic is getting in on the action.](https://longbridge.com/en/news/286135456.md) - [Anthropic hit a $30 billion revenue run rate after 80x growth — and could raise $50 billion at a valuation that surpasses OpenAI](https://longbridge.com/en/news/285848514.md) - [Miri V410 Encoder/Decoder Wins 2026 NAB Show Product of the Year and TV Tech Best of Show Awards](https://longbridge.com/en/news/285718821.md) - [Canada's Knight Therapeutics Q1 revenue jumps 69%, beats estimates](https://longbridge.com/en/news/285531982.md)